HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.

Abstract
This study evaluated the activity of cardiac and renal antioxidant enzymes [superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and glutathione reductase (GR)] and whether chronic treatment with tempol, a cell membrane-permeable SOD mimetic, ameliorates the hypertension of hyperthyroidism. Two experiments were performed. In experiment I, the following four groups of male Wistar rats were used: control group and three groups that received thyroxine (T4) at 10, 50, or 75 microg x rat(-1) x day(-1). In experiment II, tempol was orally administered (18 mg x kg(-1) x day(-1)) to control and T4-treated (75 microg x rat(-1) x day(-1)) rats. All treatments were maintained for 6 wk. Body weight, tail systolic blood pressure (BP), and heart rate were measured one time a week, and direct BP and morphological, metabolic, plasma, and renal variables were measured at the end of the experiment. Enzymatic activities were measured in renal cortex and medulla and right and left ventricles. In renal cortex, SOD activity was decreased in the T4-75 group, and there was a dose-related increase in CAT activity and decrease in GPX and GR activities in T4-treated groups. Activity of all antioxidant enzymes was reduced in left ventricle in T4-50 and T4-75 groups and in right ventricle in the T4-75 group. Tempol reduced BP, plasma malondialdehyde, and total urinary excretion of F2 isoprostanes in hypertensive hyperthyroid rats but not in controls. Tempol did not improve cardiac hypertrophy, proteinuria, or creatinine clearance in hyperthyroid rats. In conclusion, the results obtained indicate that the activity of SOD, GPX, and GR in renal and cardiac tissues is decreased in hyperthyroidism and that antioxidant treatment with tempol ameliorates T4-induced hypertension.
AuthorsJuan Manuel Moreno, Isabel Rodríguez Gómez, Rosemary Wangensteen, Antonio Osuna, Pablo Bueno, Félix Vargas
JournalAmerican journal of physiology. Endocrinology and metabolism (Am J Physiol Endocrinol Metab) Vol. 289 Issue 5 Pg. E776-83 (Nov 2005) ISSN: 0193-1849 [Print] United States
PMID15941780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Cyclic N-Oxides
  • Spin Labels
  • 8-epi-prostaglandin F2alpha
  • Malondialdehyde
  • Dinoprost
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glutathione Reductase
  • Thyroxine
  • tempol
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Blood Pressure (drug effects)
  • Catalase (metabolism)
  • Cyclic N-Oxides (pharmacology)
  • Dinoprost (analogs & derivatives, urine)
  • Glutathione Peroxidase (metabolism)
  • Glutathione Reductase (metabolism)
  • Heart Rate (drug effects)
  • Hypertension (drug therapy, enzymology, etiology)
  • Hyperthyroidism (complications, drug therapy, enzymology)
  • Kidney (enzymology)
  • Male
  • Malondialdehyde (blood)
  • Myocardium (enzymology)
  • Rats
  • Rats, Wistar
  • Spin Labels
  • Superoxide Dismutase (metabolism)
  • Thyroxine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: